FDA cracks down on diabetes drug fraudsters
This article was originally published in Scrip
Executive Summary
The US FDA on 23 July issued letters to 15 companies selling potentially harmful products to US diabetes patients claiming the therapies treat, cure, prevent or mitigate diabetes and related complications, such as blindness, nerve damage, kidney failure, heart disease and lower-extremity amputations.